Cargando…
P19 IV antimicrobial duration in practice
BACKGROUND: Tackling antimicrobial resistance by reducing unnecessary or inappropriate prescribing is a key priority. OBJECTIVES: To review current clinical practice at Guy's and St Thomas’ Hospital around duration of IV antimicrobial therapy framed with Start Smart Then Focus national guidelin...
Autores principales: | Akintimehin, Abisoye O., Wade, Paul, Brown, Aisling F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849424/ http://dx.doi.org/10.1093/jacamr/dlac004.018 |
Ejemplares similares
-
P17 Vancomycin therapeutic drug monitoring—a call for change?
por: Payne, Lara, et al.
Publicado: (2022) -
128. Development of an Analytics Dashboard to Monitor Antimicrobial Selection and Duration for Pneumonia
por: Marx, Ashley, et al.
Publicado: (2021) -
64. Impact of a Duration Bundle on Antimicrobial Use in a Pediatric Hospital
por: Weslander, Erin, et al.
Publicado: (2020) -
68. Impact of a Pharmacy-Driven Antimicrobial Time-out on Duration of Therapy in Community-Acquired Pneumonia
por: Patel, Amolee R, et al.
Publicado: (2020) -
Outcomes of a National Cohort of Children with Acute Severe Ulcerative Colitis
por: Akintimehin, Abisoye O., et al.
Publicado: (2018)